SB1258 - 104th General Assembly

PRIOR AUTH-PRESCRIPTION DRUGS
Last Action
5/09/2025 - Senate: Rule 3-9(a) / Re-referred to Assignments
Senate Sponsors
Sen. Graciela Guzmán and Rachel Ventura
Statutes Amended In Order of Appearance
215 ILCS 200/52 new
Synopsis As Introduced
Amends the Prior Authorization Reform Act. Provides that a health insurance issuer may not require prior authorization for: a prescription drug prescribed to a patient by a health care professional for 6 or more consecutive months, regardless of whether the prescription drug is a non-preferred medication pursuant to the patient's health insurance coverage; the following prescription drugs or the therapeutic equivalent approved by the United States Food and Drug Administration: insulin; human immunodeficiency virus prevention medication; human immunodeficiency virus treatment medication; viral hepatitis medication; estrogen; and progesterone; or human immunodeficiency virus pre-exposure prophylaxis and post-exposure prophylaxis drugs approved by the United States Food and Drug Administration; Truvada; Harvoni; Descovy; and Apretude.
Actions
Date Chamber Action
1/28/2025 Senate Filed with Secretary by Sen. Graciela Guzmán
1/28/2025 Senate First Reading
1/28/2025 Senate Referred to Assignments
3/04/2025 Senate Added as Co-Sponsor Sen. Rachel Ventura
3/12/2025 Senate Assigned to Insurance
3/21/2025 Senate Rule 2-10 Committee Deadline Established As April 4, 2025
4/04/2025 Senate Rule 2-10 Committee Deadline Established As April 11, 2025
4/11/2025 Senate Rule 2-10 Committee/3rd Reading Deadline Established As May 9, 2025
5/09/2025 Senate Rule 3-9(a) / Re-referred to Assignments